Legal Battle Over E-Cigarette Ban: Constitutionality Challenge in Kentucky

Regulations by 2FIRSTS.ai
Jul.09.2024
Legal Battle Over E-Cigarette Ban: Constitutionality Challenge in Kentucky
Kentuckylantern reported on July 8 that Judge Thomas Wingate heard a case questioning the constitutionality of a law banning e-cigarette sales.

According to Kentucky Lantern's report on July 8th, Judge Thomas Wingate of the Franklin Circuit Court presided over a case on Monday (the 8th) questioning the constitutionality of a law banning the sale of certain e-cigarette products.

 

The defendants in the case, Allyson Taylor, the Director of the Alcohol Beverage Control Board in the state of Kentucky, and Secretary of State Michael Adams, have filed a motion to dismiss the case.

 

If Governor Whitaker approves this request, the plaintiffs, including the Kentucky E-Cigarette Retailers Association, the Kentucky Cannabis Association, and four e-cigarette sales shops, will appeal the decision. The plaintiffs have also filed a request for the court to make a judgment. However, the case is far from being resolved. Whitaker stated that he will need "some time" to review the matter.

 

This lawsuit centers around House Bill 11, which was passed in the legislative assembly in 2024. Supporters of the bill argue that it is a way to curb the use of e-cigarettes by minors by restricting the sale of "authorized products" or products that have obtained a "safe harbor certification" based on guidelines from the US FDA. Opponents argue that this will harm small businesses and lead to monopolies by large retailers.

 

According to records from the Legislative Ethics Commission, the tobacco giant Altria (previously known as Philip Morris) has lobbied for legislation in Kentucky and other states. The company has also entered the e-cigarette market, selling a variety of FDA-approved e-cigarette products.

 

Greg Troutman, the lawyer for the Kentucky Smoke Free Association, expressed to the judge on Monday that one of the many issues with the new law is how it defines "vapor products" and "other substances," lumping e-cigarettes and marijuana products together. He believes that this combination makes the law too broad and arbitrary, and it does not adhere to the constitution.

 

Troutman argued that the title of the bill, "The Nicotine Products Act," does not accurately represent the content of the legislation.

 

Assistant Attorney Lindsey Keiser rebutted by saying that headlines do not need to fully summarize the content of the bill.

 

It is a long-established fact that headlines do not need to include all the items contained in the bill.

 

The limited number of FDA approvals signifies concerns about these products. Therefore, Kentucky has ample reason to say, "If the FDA is only approving such a limited number, we should also strive to minimize the number approved.

 

Trotman argued that the state's regulations are flawed because they are built upon a flawed federal system.

 

Our state program was established before the federal program, which has itself been found arbitrary by at least two federal courts.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | DOJO Launches BLAST10K Fresh in UK With 0+10ml E-Liquid Structure, Retaining 2+8ml Pod Compatibility
Product | DOJO Launches BLAST10K Fresh in UK With 0+10ml E-Liquid Structure, Retaining 2+8ml Pod Compatibility
DOJO launched the BLAST10K Fresh in the UK on September 4, 2026, introducing its INSTA-JUICED™ technology and a new 0+10ml structure that keeps e-liquid separated from the coil before activation. The device features a 1000mAh rechargeable battery, COREX BLAST dual-mesh technology and SSS leak-resistant technology, with a manufacturer-rated capacity of up to 10,000 puffs. It also retains compatibility with existing 2+8ml pods across the BLAST ecosystem. The launch introduces eight new flavors, including Matcha Strawberry, which DOJO describes as an industry first.
Market
Sep.04
UK HMRC Issues One-Month Countdown Warning, Urges Vape Businesses to Prepare for New Tax Rules
UK HMRC Issues One-Month Countdown Warning, Urges Vape Businesses to Prepare for New Tax Rules
The UK’s Vaping Products Duty and Vaping Duty Stamps Scheme will take effect on October 1, 2026. All vaping liquids manufactured in or imported into the UK will face a flat excise duty of £2.20 per 10ml, whether or not they contain nicotine. Newly manufactured or imported products released onto the UK market from October 1 will require a valid duty stamp, while eligible existing unstamped inventory can continue to be sold through March 31, 2027. From April 1, 2027, all vaping products outside duty suspension must carry a valid stamp.
Sep.03
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
The U.S. FDA has consolidated two tobacco establishment registration and product listing forms into a redesigned Form FDA 3741 covering all regulated product categories, including e-cigarettes, heated tobacco products and nicotine pouches. The current requirements remain limited to domestic establishments. Separately, the FDA has proposed extending registration and product listing requirements to foreign manufacturers, signaling greater regulatory attention to manufacturing entities and product-level information across the tobacco and nicotine supply chain.
FDA
Sep.30
South Korea Extends Vape Rules to Unmanned Stores After Bringing Synthetic Nicotine Under Tobacco Law
South Korea Extends Vape Rules to Unmanned Stores After Bringing Synthetic Nicotine Under Tobacco Law
South Korea's Ministry of Gender Equality and Family said on September 14 that it plans to designate unmanned e-cigarette stores as businesses where minors are prohibited from entering or working. Operators would be required to verify customers' ages and display notices restricting access by minors. The proposal is open for public comment through October 6. The move follows an April expansion of South Korea's statutory tobacco definition that brought products made with natural or synthetic nicotine under the Tobacco Business Act. Nicotine-free liquids and products using nicotine analogues such as 6-methylnicotine, however, remain an emerging regulatory issue.
Sep.21
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14